+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are evaluating the effectiveness and safety of lebrikizumab, a drug given by injection, in people aged 12 and older with chronic rhinosinusitis and nasal polyps who are also treated with intranasal corticosteroids. This phase 3 trial aims to improve symptoms like nasal congestion and polyp size while monitoring participant safety over about 18 months. Participants receive lebrikizumab injections on different schedules or placebo injections, all along with standard intranasal corticosteroid spray. Adolescents aged 12 to under 18 who weigh at least 40 kg are assigned to open-label lebrikizumab treatment. The study includes multiple groups receiving injections every 2, 4, or 8 weeks to compare outcomes. During the study, participants will undergo assessments including nasal congestion scoring, endoscopic evaluation of nasal polyps, sinus imaging, lung function tests, and symptom questionnaires from the start through 24 weeks. Safety and symptom changes are closely monitored, and the total study duration is approximately 18 months.

Age: 12Years +All GendersPhase 3
202 locations
P

Actively Recruiting

Researchers are investigating how a rehabilitation and treatment stay at the underground Health Resort of the Wieliczka Salt Mine affects elderly individuals aged 65 and older who have chronic respiratory diseases. This prospective, experimental study with a controlled crossover design aims to assess changes in functional capacity, respiratory parameters, and the flow properties of blood in these participants. The study involves a 3-week rehabilitation and therapeutic stay in the underground salt chambers, where participants receive daily 2.5-hour pulmonary rehabilitation sessions supervised by a doctor, physiotherapist, and nurse. Before the stay, participants undergo qualifying tests, including functional fitness and respiratory assessments, and blood rheology tests are performed at four time points three weeks before, immediately before, right after the stay, and three months after completion. Participants will be monitored through various tests such as respiratory muscle strength measurements, walking and gait speed tests, blood markers including interleukins and blood cell counts, and quality of life questionnaires. The study also includes assessments of chest mobility and blood inflammation markers. Follow-up evaluations will continue up to 18 months to observe longer-term effects of the rehabilitation program.

Age: 65Years +All GendersPhase Not Applicable
1 location